Business Development
Immunotope
is seeking commercial partnerships with biotechnology and pharmaceutical
companies that develop immunotherapeutic vaccines, monoclonal antibody
therapeutics and diagnostic tests for cancer and infectious diseases. Antigens
available for outlicensing We
have a variety of novel antigens available for clinical evaluation and outlicensing:
Ovarian
tumor antigens Breast
tumor antigens Antibody
therapeutic targets Cancer
diagnostic targets Ovarian
and prostate theranostic targets
For
infectious diseases, we are seeking partnerships for antigen discovery,
validation and development of therapeutic vaccines for Hepatitis B, Hepatitis C,
Dengue virus, West Nile virus, smallpox and influenza.
.....................................................................................................................................................................
Clinical and Preclinical Programs | Science & Technology | Careers
Business Development |
Services
| Management and
Boards | News
and Media | Contact Us |
Home